The FDA has approved ProVate (ConTIPI) for the temporary, nonsurgical management of pelvic organ prolapse in women. The Food and Drug Administration (FDA) has approved ProVate (ConTIPI) for the ...
CHICAGO, Dec. 10, 2024 /PRNewswire/ -- ConTIPI Medical, an innovator in providing non-surgical and disposable solutions for women with various pelvic floor dysfunctions, and EVERSANA, a leading ...
CHICAGO, Aug. 27, 2024 /PRNewswire/ -- ConTIPI Medical, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor dysfunctions, has selected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results